![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, August 19, 2022 12:55:54 PM
2022 will be the 13th consecutive year that they were 'wrong gain'.
Some other 'Greatest Hits' Opinions that were 100% Wrong:
BIEL will never get ActiPatch Reclassified to a Class 2 Device. (10/14/2015 ActiPatch Reclassified as FDA Class 2 Medical Device, this opened the door to a OTC Clearance)
BIEL will never get 'Over the Counter' FDA Clearance. (2/3/2017 FDA OTC Clearance for Knee/Foot, 1/31/2020 FDA OTC Clearance for Musculoskeletal Pain)
BIEL will never get a FDA Clearance. (BIEL now has 5 FDA Clearances)
BIEL will never get the CE Mark renewed. (11/12/2020 BIEL granted CE Mark for ActiPatch and RecoveryRx)
BIEL will never get distribution with a major medical products company. (2/2022 $3 billion STADA distribution agreement in MENA)
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM